Stay Updated with the Latest Merck & Co., Inc. MRK News in Real Time
Find MRK news now at Meyka AI. Stay informed with the latest Merck & Co., Inc. stocks updates, including price news, market analysis, and expert insights.
Bitcoin Price Today: BTC Soars 8% to $74,982 as Crypto Rally Explodes; Ethereum, XRP Surge
Bitcoin surged 8% to $74,982 on Friday, August 21, 2026, extending a powerful weekly rally. The cryptocurrency has now climbed nearly 20% since Monday, fueled by a surprise US Treasury policy shift. Ethereum jumped toward $2,300, gaining roughly 18% in 24 hours, while XRP surged past $1.25. Total crypto market capitalization reached $2.56 trillion, up…
Tech Stocks to Watch: Alphabet Lifts 2026 Capex Forecast to $195B-205B
Alphabet is spending more to keep up with demand for artificial intelligence. On July 22, 2026, the Google parent raised its 2026 capital expenditure forecast to $195 billion-$205 billion, up from $180 billion-$190 billion. The increase comes as Google Cloud revenue jumped 82% to $24.8 billion in the second quarter. As AI demand drives higher…
Moderna Tumbles 23.5% After 177% Surge on Cancer Vaccine Win, August 21
Moderna stock fell 23.5% to $133.32 on August 21 after surging 177% the prior day on its cancer vaccine breakthrough with Merck. RSI hit record 92.21, signaling extreme overbought conditions.
Moderna Soars 122% on Melanoma Vaccine Breakthrough, August 21
Moderna stock jumps 122% after announcing its personalized mRNA melanoma vaccine met Phase 3 trial goals. The vaccine reduced cancer recurrence and spread when combined with Merck’s Keytruda.
Moderna Soars 177% on Melanoma Vaccine Win; Merck Gains 12% on August 20
Moderna jumps 177% and Merck rises 12% after their mRNA cancer vaccine meets Phase 3 endpoints for melanoma. The combo reduced cancer recurrence and spread in over 1,100 patients.
Crypto Prices Today: Bitcoin Hits $69,551, Ethereum Gains 17.74% as Hyperliquid Surges 20.97%
Crypto prices surged sharply on Thursday, August 20, 2026, breaking weeks of sideways trading. Bitcoin jumped to $69,551, gaining roughly 8% in 24 hours. Ethereum climbed 17.74% to reclaim the $2,000 level, while Hyperliquid’s HYPE token surged 20.97%. The rally followed a surprise US Treasury announcement to double its long-dated bond buyback operations. Total crypto…
NVDA Stock, AMD Stock, Micron and Broadcom Gain as AI Spending Estimates Rise
AI spending estimates are rising again, giving semiconductor stocks a fresh boost. On August 7, 2026, Goldman Sachs estimated global AI investment could reach about $1 trillion this year, above widely cited hyperscaler spending forecasts. That outlook is supporting demand for AI chips, memory and networking hardware. As a result, NVDA stock, AMD stock, Micron…
Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20
Moderna stock jumped 177% after its melanoma vaccine met Phase 3 trial endpoints. The personalized mRNA therapy showed significant improvements over standard treatment in over 1,100 patients.
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.